VHCP Management III’s Myovant Sciences Ltd. MYOV Stock Holding History

VHCP Management III’s Portfolio MYOV Stock Details MYOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$7.07M	Buy	+455,255	New	+$4.59M	1.4%	14

Other funds holding MYOV

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

NCM

NovaQuest Capital Management Raleigh, North Carolina $54.3M AUM 163.39% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VHCP Management III's MYOV Position: Q4 2019 in Review

VHCP Management III opened a new position in Myovant Sciences Ltd. (MYOV) in Q4 2019: 455,255 shares worth $7.07M. The stake represents 1.4% of the portfolio and ranks #14 among its holdings.

77 funds tracked by Wall St. Rank hold MYOV as of Q4 2019.

VHCP Management III held 455,255 shares of Myovant Sciences Ltd. worth $7.07M as of Q4 2019.
Myovant Sciences Ltd. was a new VHCP Management III position in Q4 2019.
Myovant Sciences Ltd. made up 1.4% of VHCP Management III's portfolio in Q4 2019, its #14 holding.
77 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q4 2019.

Based on VHCP Management III's 13F filing for Q4 2019, filed 13 Feb 2020.